Nature Communications

Chronic infection triggers senescence in mouse immune cells

Lab experiments followed mouse immune cells for up to five days and found that secreted signals spread senescence to uninfected neighbors.

Fig. 1. Chronic Mycobacterium abscessus infection in vitro alters macrophage morphology and replication.
Open the figure at full size
Fig. 1. Chronic Mycobacterium abscessus infection in vitro alters macrophage morphology and replication.Chronic Mycobacterium abscessus infection in vitro alters macrophage morphology and replication.Scarpa et al.
Studied:
Experiments in murine macrophages, 5 days, against uninfected controls
What changed:
Infected macrophages showed increased senescence, with ~75% staining positive against uninfected controls
The catch:
The spatial dataset included only a single infected animal and a single uninfected control
In the record:
One of 292 papers on navitoclax on record: 20 with results in people, 84 in animals. Its result on senescent cells agrees with all 3 other findings on record.

Editor of record: Boris Djordjevic · AgingResearch.News

Follow @agingbrief

Mouse alveolar-like macrophages—lab-grown immune cells resembling those in the lung—entered senescence after infection with the bacterium Mycobacterium abscessus. Senescence is a state in which cells stop dividing. In this laboratory experiment, researchers exposed cells to bacteria for two hours, then followed them for up to five days.

DNA damage emerged as the main driver of senescence. Infected cells released signals that spread senescence to neighboring, uninfected cells. The authors concluded that this process created an inflammatory environment that helped bacteria persist and evade immune clearance. In the cell model, researchers also tested navitoclax, a drug that selectively kills senescent cells, after an antibiotic. It eliminated senescent cells and reduced the amount of bacteria.

Why it matters

The authors propose targeting senescent host cells as a way to complement antibiotics against chronic infection, rather than targeting the bacteria alone.

Caveats

The drug results came from lab-grown mouse cells, not from treatment of infected animals or people.

Comments

Be the first to comment.